Ulys, L.L.C.
- SEC CIK
- 0001340098
No open-market purchases or sales filed in the past year.
Current role at each company
- LXRX Lexicon Pharmaceuticals, Inc.Director, 10% Owneras of Aug 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ulys, L.L.C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 (view filing)4:48 PM ET | Aug 5 | 4 days | Debbane Raymond and 2 othersDirector, 10% Owner | PPurchase | +147.4K | $2.50 | +$368.5K | +2.8%5.45M after | |
| Aug 1, 2022 (view filing)4:15 PM ET | Aug 1 | Same day | Debbane Raymond and 2 othersDirector, 10% Owner | PPurchase | +982.6K | $2.50 | +$2.46M | +22.7%5.30M after | Duplicate filing |